A case of enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction which was successfully treated with somatostatin analogue.
Enterochromaffin-like cell neuroendocrine tumor
Hypergastrinemia
Parietal cell dysfunction
Somatostatin analogue
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Apr 2022
Apr 2022
Historique:
received:
03
11
2021
accepted:
18
12
2021
pubmed:
5
1
2022
medline:
1
4
2022
entrez:
4
1
2022
Statut:
ppublish
Résumé
We report here a case of a 62-year-old woman with multiple gastric enterochromaffin-like cell neuroendocrine tumor caused by hypergastrinemia due to parietal cell dysfunction that was successfully treated with somatostatin analogue. Esophagogastroduodenoscopy revealed several G1 neuroendocrine tumors, 10 mm in diameter, in the body of the stomach. No evidence of autoimmune gastritis, Helicobacter pylori infection, neuroendocrine neoplasia type 1, or Zollinger-Ellison syndrome was identified. The pattern of immunohistochemical staining of the background gastric mucosa was suggestive of parietal cell dysfunction. She was treated with long-acting release octreotide acetate. Complete response was confirmed after 9 months and was maintained for 22 months.
Identifiants
pubmed: 34982362
doi: 10.1007/s12328-021-01581-6
pii: 10.1007/s12328-021-01581-6
doi:
Substances chimiques
Gastrins
0
Somatostatin
51110-01-1
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
363-367Informations de copyright
© 2022. Japanese Society of Gastroenterology.
Références
Rindi G, Luinetti O, Cornaggia M, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104:994–1006.
doi: 10.1016/0016-5085(93)90266-F
Ooi A, Ota M, Katsuda S, et al. An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocr Pathol. 1995;6:229–37.
doi: 10.1007/BF02739887
Abraham SC, Carney JA, Ooi A, et al. Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids: a new disorder. Am J Surg Pathol. 2005;29:969–75.
doi: 10.1097/01.pas.0000163363.86099.9f
Nakata K, Aishima S, Ichimiya H, et al. Unusual multiple gastric carcinoids with hypergastrinemia: report of a case. Surg Today. 2010;40:267–71.
doi: 10.1007/s00595-009-4032-7
Ishioka M, Hirasawa T, Kawachi H, et al. Enterochromaffin-like cell neuroendocrine tumor associated with parietal cell dysfunction. Gastrointest Endosc. 2019;90:841-845.e1.
doi: 10.1016/j.gie.2019.06.029
Ferraro G, Annibale B, Marignani M, et al. Effectiveness of octreotide in controlling fasting hypergastrinemia and related enterochromaffin-like cell growth. J Clin Endocrinol Metab. 1996;81:677–83.
pubmed: 8636288
Campana D, Nori F, Pezzilli R, et al. Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs. Endocr Relat Cancer. 2008;15:337–42.
doi: 10.1677/ERC-07-0251